Samsara BioCapital, LLC — 13F holdings

Samsara BioCapital, LLC reported 24 holdings worth $1.22B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. SRRK SCHOLAR ROCK HLDG CORP — $379M (31.2%)
2. ALMS ALUMIS INC — $179M (14.7%)
3. MLYS MINERALYS THERAPEUTICS INC — $158M (13.0%)
4. SEPN SEPTERNA INC — $105M (8.7%)
5. ALMR ALAMAR BIOSCIENCES INC — $67.2M (5.5%)
6. NGNE NEUROGENE INC — $54.0M (4.4%)
7. KLRS Kalaris Therapeutics Inc — $52.4M (4.3%)
8. SGP SPYGLASS PHARMA INC — $47.0M (3.9%)
9. STRO SUTRO BIOPHARMA INC — $35.3M (2.9%)
10. IVA INVENTIVA SA — $23.9M (2.0%)